Cytomegalovirus Infection


Risk

  • Seroprevalence increases with age and low socioeconomic status in USA: From 58.9% in those aged ≥6 y to 90.8% in those ≥80 y. Also higher in non-Hispanic blacks, Mexican Americans, and women.

  • Severe disease from CMV is rare in immunocompetent individuals.

  • Risk for CMV disease in transplant recipients: 10–40% with preventive measures.

  • Risk for CMV disease in HIV-positive pts: 20–30% (increased risk with low CD4 count).

  • Approximately 1:150 children is born with congenital CMV.

Perioperative Risks

  • CMV transmission from tissue or blood products from a CMV-seropositive donor to a seronegative recipient

  • Related to severity of CMV-induced organ dysfunction (if present): Pulmonary, CNS, hepatic, GI, cardiac, bone marrow, adrenal

Worry About

  • Giving CMV-seropositive blood products to a CMV-seronegative immunocompromised host; filters that remove leukocytes from the blood can be used to prevent transmission of CMV if CMV-seropositive blood donors are used.

  • Abnormal hepatic metabolism if CMV hepatitis is present may alter drug clearance.

  • Elevated ICP if CMV encephalitis/meningitis.

  • Abnormal oxygenation if CMV pneumonitis.

  • Myocardial dysfunction or arrhythmias if CMV myocarditis.

  • Perforated viscus secondary to colonic/gastric CMV.

  • Bone marrow suppression resulting in abnormal bleeding from thrombocytopenia, anemia, and neutropenia.

  • Adrenal insufficiency due to CMV adrenalitis.

Overview

  • Double-stranded DNA betaherpesvirus; member of the Herpesviridae family—largest virus to infect humans.

  • Vast majority of North American adults have had prior exposures and are CMV seropositive.

  • Establishes latency after primary infection. Secondary infection occurs after reactivation of a latent virus in an immunocompromised host.

  • Transmission through close contact, blood and blood products, organ transplantation, and sexually and perinatally.

Manifestations

  • Immunocompetent host: Asymptomatic, heterophile antibody–negative mononucleosis-like syndrome

  • Immunocompromised host: Symptomatic or asymptomatic viremia with or without organ involvement—retinitis, encephalitis, meningitis, myelitis, polyneuropathy, pneumonitis, esophagitis, gastritis, colitis, hepatitis, cholangitis, myocarditis, adrenalitis, vasculitis, and bone marrow suppression

  • Neonates: Petechial rash, jaundice with hepatosplenomegaly; neurologic abnormalities, such as microcephaly and lethargy, eye involvement with chorioretinitis and optic nerve atrophy, prematurity and low birth weight, and sensorineural hearing loss

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here